SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunityBio converts from Immunomedics
IBRX 2.580-3.0%9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
To: waitwatchwander who wrote (1215)10/27/2025 3:36:15 PM
From: Stanley Lake 921 Recommendation

Recommended By
jargonweary

   of 1216
 
Scientific proof isn't often easy. I thought AF's article was fair on the mark.

One thing from the past few days that feels like it may have some import, albeit key differences in mechanisms and scope, is the retrospective, nonclinical study on mRNA vaccines and some cancer. Too much to unpack here, but attention to the immune system is a key shift and overlaps/IBRX.
nature.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News